1. A 40-Year-Old Man With Persistent Febrile Neutropenia and Subsequent Rash. (21st January 2021) Authors: Meher-Homji, Zaal; North, Daniel; Stewart, James D; Moir, Diana; Kalff, Anna; Fleming, Shaun; Ananda-Rajah, Michelle R; Fuller, Andrew; Morrissey, C Orla Journal: Clinical infectious diseases Issue: Volume 71:Number 12(2020) Page Start: 3260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16‐02 trial. (15th May 2021) Authors: Bergin, Krystal; Yuen, Flora; Wallington‐Beddoe, Craig; Kalff, Anna; Sirdesai, Shreerang; Reynolds, John; Spencer, Andrew Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Issue 8 (August 2017) Authors: Lee, Oi Lin; Horvath, Noemi; Lee, Cindy; Joshua, Doug; Ho, Joy; Szer, Jeff; Quach, Hang; Spencer, Andrew; Harrison, Simon; Mollee, Peter; Roberts, Andrew W.; Talaulikar, Dipti; Brown, Ross; Augustson, Bradley; Ling, Silvia; Jaksic, Wilfrid; Gibson, John; Kalff, Anna; Johnston, Anna; Kalro, Akash Journal: Internal medicine journal Issue: Volume 47:Issue 8(2017) Page Start: 938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Central nervous system multiple myeloma – potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains. (29th May 2013) Authors: Lee, Denise; Kalff, Anna; Low, Michael; Gangatharan, Shane; Ho, Prahlad; Bajel, Ashish; Ritchie, David; Grigg, Andrew; Spencer, Andrew Journal: British journal of haematology Issue: Volume 162:Number 3(2013:Aug.) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD). Issue 12 (15th October 2021) Authors: Kalff, Anna; Khong, Tiffany; Ramachandran, Malarmathy; Walker, Patricia; Schwarer, Anthony; Roberts, Andrew W.; Campbell, Philip; Filshie, Robin; Norton, Sam; Reynolds, John; Young, Mary; Pierceall, William; Thakurta, Anjan; Guo, Manman; Oppermann, Udo; Wang, Maria; Ren, Yan; Kennedy, Nola; Parek... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 2981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma. Issue 12 (2nd December 2018) Authors: Yuen, Hiu Lam Agnes; Low, Michael Sze Yuan; Fedele, Pasquale; Kalff, Anna; Walker, Patricia; Bergin, Krystal; Coutsouvelis, John; Grigoriadis, George; Spencer, Andrew Journal: Leukemia & lymphoma Issue: Volume 59:Issue 12(2018) Page Start: 2842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia. Issue 10 (18th October 2021) Authors: Creeper, Katherine; Augustson, Bradley; Kusel, Kieran; Fulham, Michael J.; Ho, Joy; Quach, Hang; Mollee, Peter; Weber, Nicholas; Talaulikar, Dipti; Johnston, Anna; Murphy, Nick; Joshua, Douglas; Ward, Christopher; Ling, Silvia; Gibson, John; Szer, Jeff; Harrison, Simon; Zannettino, Andrew; Jaksic... Journal: Internal medicine journal Issue: Volume 51:Issue 10(2021) Page Start: 1707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study). Issue 9 (29th July 2019) Authors: Kalff, Anna; Khong, Tiffany; Mithraprabhu, Sridurga; Bergin, Krystal; Reynolds, John; Bowen, Kathryn M.; Thakurta, Anjan; Guzman, Roberto; Wang, Maria; Couto, Suzana; Ren, Yan; Spencer, Andrew Journal: Leukemia & lymphoma Issue: Volume 60:Issue 9(2019) Page Start: 2143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT study. Issue 9 (29th July 2019) Authors: Horvath, Noemi; Spencer, Andrew; Kenealy, Melita; Joshua, Douglas; Campbell, Philip J; Lee, Je-Jung; Hou, Jian; Qiu, Lugui; Kalff, Anna; Khong, Tiffany; Londhe, Anil; Siggins, Sarah; van Kooten Losio, Maximiliano; Eisbacher, Michael; Prince, H. Miles Journal: Leukemia & lymphoma Issue: Volume 60:Issue 9(2019) Page Start: 2122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II trial of single‐agent panobinostat consolidation improves responses after sub‐optimal transplant outcomes in multiple myeloma. (18th September 2020) Authors: Mithraprabhu, Sridurga; Kalff, Anna; Gartlan, Kate H.; Savvidou, Ioanna; Khong, Tiffany; Ramachandran, Malarmathy; Cooke, Rachel E.; Bowen, Kathryn; Hill, Geoffrey R.; Reynolds, John; Spencer, Andrew Journal: British journal of haematology Issue: Volume 193:Number 1(2021) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗